This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Sanofi. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Michael Spitzenberg: Innovator in Pharmaceutical Chemistry
Introduction
Michael Spitzenberg is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that have therapeutic applications. With a total of 2 patents to his name, his work is recognized for its potential impact on medical treatments.
Latest Patents
Michael Spitzenberg's latest patents include advancements in crystalline salts of R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1H-imidazol-4-yl)-propionic acid. The first patent describes a sodium salt of this compound, which is presented in a crystalline form or at least partially crystalline form as a monohydrate or anhydrate. This invention also outlines a process for its preparation and methods for using the salt to treat conditions that can be improved by administering an inhibitor of the enzyme TAFIa (activated thrombin-activatable fibrinolysis inhibitor). The second patent similarly focuses on the sodium salt of the same compound, emphasizing its crystalline properties and therapeutic applications.
Career Highlights
Michael is currently employed at Sanofi, a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to create innovative solutions for health challenges. His contributions have been instrumental in advancing the company's portfolio of therapeutic agents.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Norbert Nagel and Bruno Baumgartner. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to successful outcomes in their projects.
Conclusion
Michael Spitzenberg stands out as a dedicated inventor in the pharmaceutical industry, with a focus on developing innovative compounds that hold promise for medical treatments. His work at Sanofi and his patented inventions reflect his commitment to advancing healthcare solutions.